Best of ASCO - 2014 Annual Meeting

 

Welcome

Late and Long-Term Effects

Symptoms and Survivorship

2019 ASCO Annual Meeting

Sort by: title abstract no. first author
ABSTRACT TITLEFIRST AUTHORABSTRACT NO.
A pilot study of oncology massage to treat chemotherapy-induced peripheral neuropathy (CIPN).

Gabriel Lopez

e23067

A prospective study of anti-mullerian hormone (AMH) as a predictor of chemotherapy-induced menopause.

Bogda Koczwara

e23076

Acupuncture versus cognitive behavioral therapy for cognitive impairment in cancer survivors with insomnia: Implications for personalized medicine.

Jun J. Mao

11522

Association of baseline cardiovascular risk factors and health care utilization and costs in elderly breast cancer patients enrolled in SWOG clinical trials.

Dawn L. Hershman

11508

Body weight changes in young breast cancer survivors and associated predictors.

Tal Sella

11574

Cancer survivors’ challenges with ostomy appliances and self-management.

Virginia Sun

e23091

Candidate SNPs enhance prediction of cognitive impairment after blood or marrow transplantation (BMT) for hematologic malignancy (HM).

Noha Sharafeldin

11520

Cardiorespiratory fitness and cardiovascular mortality after prolonged androgen deprivation therapy for prostate cancer.

Jingyi Gong

11576

Cardiovascular disease risk in survivors of 20 adult cancers.

Helen Strongman

11571

Chronic adverse effects after axillary lymphadenectomy in breast cancer patients after weaker and stronger postoperative analgesia: Results of a prospective double-blind randomized study.

Nikola Besic

e23066

Clinical course of patients with cisplatin (CDDP)-associated neuropathy compared to other neurotoxic chemotherapy.

Costantine Albany

e23078

Cognitive impairment and treatment effects among gastrointenstinal stromal tumor survivors: Results of a large online survey.

Robert J. Ferguson

e23092

Cognitive rehabilitation program to improve cognition of cancer patients treated with chemotherapy: A randomized controlled multicenter trial.

Mélanie Dos Santos

11521

Cutaneous eruption as a prognosis indicator for cancer patients treated with EGFR tyrosine kinase inhibitors: A systematic review and meta-analysis.

Yensheng Wang

e23063

Defining cardiotoxicity of doxorubicin and trastuzumab.

Abir Khan

e23097

Detection of bone metastases through diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) compared with PET/CT 18F-NaF.

Hector Manuel Barragan-Campos

e23086

Development of a comprehensive prognostic model of lymphedema risk for breast cancer survivors.

Jennifer Kwan

e23083

Development of the patient-reported outcomes (PRO) based survival prediction model for survivors who underwent lung cancer surgery.

Jin-Ah Sim

e23084

Effect of pre-treatment anxiety and depression on long term survival of prostate cancer patients treated radically with radiation and hormone therapy.

Santhanam Sundar

e23087

Effect of race/ethnicity on long-term cytopenias and major infections in adolescent young adult breast cancer survivors.

Candice Sauder

11568

Effect of temozolomide on neurogenesis and anxiety in the adult mouse brain.

Syed Hussaini

e23082

Fatigue in long-term survivors of acute promyelocytic leukemia (APL) and its association with other symptoms and functional limitations.

Fabio Efficace

e23073

Female fertility preservation (FP) at pediatric cancer centers: A report from the Children’s Oncology Group (COG).

Jennifer Levine

11567

High temporal variability of clinical side effects with and without adjuvant chemotherapy in 4,684 early breast cancer patients in the CANTO trial.

Paul H. Cottu

11566

Impact of cancer on physical and mental activities of daily living in young adult (YA) survivors.

Tyler Garrett Ketterl

11517

Impact of cisplatin-related hearing loss (HL) and tinnitus on patient functioning.

Shirin Ardeshirrouhanifard

e23085

Impact of overweight, obesity, and post-treatment weight changes on occupational reintegration of breast cancer (BC) survivors.

Antonio Di Meglio

11562

Implementation of a brief screening tool to identify needs of cancer survivors.

Allison L. McDonough

e23075

Implementing a web-based patient reported outcomes (PRO) assessment: Uptake, usability, and lessons learned.

Linda A. Jacobs

e23062

Implementing strain imaging to identify early childhood cancer survivors at risk for cardiovascular disease.

Wendy Bottinor

e23070

Incidence of Infection-related mortality in cancer patients: Trend and survival analysis.

Muhammed Khaled Elfaituri

e23095

Is in vivo reflectance confocal microscopy a useful assessment tool in chemotherapy-induced peripheral neuropathy (CIPN)?

Sabrina Ramnarine

e23088

Knowledge and attitudes of permanent chemotherapy-induced alopecia among health care providers.

Jenna Rose Stoehr

e23074

Long-term neurotoxicity in women with breast cancer.

Fahad Ahmed Faruqi

e23089

Long-term symptom burden and quality of life in metastatic melanoma patients treated with checkpoint inhibitors.

Maha Mamoor

e23090

Metastatic presentations of previously treated early stage breast cancer patients.

Najla Itani

e23065

Needs assessment for sexual health support following cancer diagnosis.

Lindsay Louise Welton

e23071

Neurocognitive outcomes in adult survivors of neuroblastoma: A report from the Childhood Cancer Survivor Study.

Caroline Hesko

11563

Osteonecrosis of the jaw in patients with cancer receiving zoledronic acid for bone metastases: SWOG S0702, NCT00874211.

Catherine H. Van Poznak

11502

Patient-reported outcomes for dental health, shoulder-neck dysfunction, and overall quality of life after treatment with radiation for head and neck cancer.

Neha Verma

e23064

Percutaneous pericardiocentesis versus pericardial window: A retrospective subset analysis in a cancer population.

Benjamin C Hofeld

e23093

Persistent radiation-induced alopecia in patients with central nervous system tumors and head and neck sarcomas.

Gregory S. Phillips

e23072

Pilot study investigating an oncofertility program in adults with breast or sarcoma cancers.

Manali A. Bhave

e23096

Polypharmacy risk among five-year cancer survivors.

Christine D. Hsu

11565

Prediction of treatment (tx)-induced fatigue in breast cancer (BC) patients (pts) using machine learning on genome-wide association (GWAS) data in the prospective CANTO cohort.

Sangkyu Lee

11515

Prospective trial in early-stage breast cancer (EBC) patients (pts) submitted to nutrition evidence-based educational intervention: Early results of adherence to dietary guidelines (ADG) and body weight change (BWC).

Luisa Carbognin

11575

Return to work after breast cancer: Comprehensive longitudinal analyses of its determinants.

Agnes Dumas

11564

Safety of pregnancy following breast cancer (BC) in patients (pts) carrying a BRCA mutation (mBRCA): Results of an international cohort study.

Matteo Lambertini

11506

Second solid (SMN) and hematologic malignant neoplasms (HMN) among 24,900 United States testicular cancer survivors (TCS) after chemotherapy (CHEM), radiotherapy (RT), or surgery only (SURG).

Mohammad Issam Abu Zaid

11573

Systematic review and meta-analysis of definitions and reported incidences of anthracycline cardiotoxicity.

Sae Jang

e23081

Temporal trends among survivors of rhabdomyosarcoma: A report from the Childhood Cancer Survivor Study (CCSS).

Pooja Hingorani

11570

The CAROLE (CArdiac Related Oncologic Late Effects) Study: A Phase II, single-arm feasibility trial.

Lindsay Puckett

11569

The impact of chemotherapy on sleep quality in women undergoing cytotoxic treatment for breast, ovarian, and endometrial cancer.

Evelyn Cantillo

e23077

Total body irradiation (TBI) and risk of breast subsequent malignant neoplasm (SMN) after blood or marrow transplantation (BMT): A report from the BMT survivor study (BMTSS).

Andrew Michael McDonald

11572

Understanding and predicting fatigue, cardiovascular (CV) decline, and events after breast cancer treatment (UPBEAT): A prospective cardio-oncology study.

Kerryn Reding

TPS11634